Diaverum is the second largest corporate dialysis clinic operator in Europe with ancillary businesses in South America and Australia. Headquartered in Sweden, it has over 225 clinics in 15 countries serving over 17,250 patients.
| www.diaverum.com | ||||
| Sector | Healthcare | Location | Stockholm | |
| Acquired | 2007 | Deal size | N/D | |
Originally part of a larger quoted medical technology group, Diaverum was identified as a non-core asset when Bridgepoint acquired the business. The company treats patients suffering from end stage renal disease who must undergo dialysis (on average 150 treatments a year) to eliminate toxins and fluids arising from failing kidney function. The company operates in a sector with attractive long-term market dynamics where the number of patients requiring dialysis treatment is growing by 5-7% p.a.
